Wikidata

(Q27852071)

English

Phase II randomized study of trastuzumab emtansine versus trastuzumab plus docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer

scientific article

In more languages

Statements

title
Phase II randomized study of trastuzumab emtansine versus trastuzumab plus docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer (English)
1 reference
stated in
PubMed
PubMed ID
23382472
retrieved
13 November 2016
author
Edith A. Perez
series ordinal
12
object named as
Edith A Perez
0 references
author name string
Sara A Hurvitz
series ordinal
1
0 references
Luc Dirix
series ordinal
2
0 references
Judit Kocsis
series ordinal
3
0 references
Giulia V Bianchi
series ordinal
4
0 references
Janice Lu
series ordinal
5
0 references
Jeferson Vinholes
series ordinal
6
0 references
Ellie Guardino
series ordinal
7
0 references
Chunyan Song
series ordinal
8
0 references
Barbara Tong
series ordinal
9
0 references
Vivian Ng
series ordinal
10
0 references
Yu-Waye Chu
series ordinal
11
0 references
publication date
20 March 2013
0 references
volume
31
0 references
page(s)
1157-63
0 references
issue
9
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q27852071&oldid=1672275473"